Key result
Belgian TGFB3 founder variant shows ~15% penetrance for thoracic aortic disease, lower than published cohorts.
Why the study?
TGFB3 variants cause Loeys-Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection, but the exact disease phenotype is difficult to delineate because of few identified cases and highly variable clinical representation.
Observational (n=27)
No
Answers are grounded in this paper and cite their sources.
Supports individualized penetrance estimates for this TGFB3 founder variant; leaves open prospective validation before refining surveillance protocols.
Background:TGFB3 variants cause Loeys–Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection. The exact disease phenotype is hard to delineate because of few identified cases and highly variable clinical representation. Methodology: We provide the results of a haplotype analysis and a medical record review of clinical features of 27 individuals from 5 different families, originating from the Campine region in Flanders, carrying the NM_003239.5(TGFB3):c.787G>C p.(Asp263His) likely pathogenic variant, dbSNP:rs796051886, ClinVar:203492. The Asp263 residue is essential for integrin binding to the Arg-Gly-Asp (RGD) motif of the TGFβ3-cytokine. Results: The haplotype analysis revealed a shared haplotype of minimum 1.92 Mb and maximum 4.14 Mb, suggesting a common founder originating >400 years ago. Variable clinical features included connective tissue manifestations, non-aneurysmal cardiovascular problems such as hypertrophic cardiomyopathy, bicuspid aortic valve, mitral valve disease, and septal defects. Remarkably, only in 4 out of the 27 variant-harboring individuals, significant aortic involvement was observed. In one family, a 31-year-old male presented with type A dissection. In another family, the male proband (65 years) underwent a Bentall procedure because of bicuspid aortic valve insufficiency combined with sinus of Valsalva of 50 mm, while an 80-year-old male relative had an aortic diameter of 43 mm. In a third family, the father of the proband (75 years) presented with ascending aortic aneurysm (44 mm). Conclusion: The low penetrance (15%) of aortic aneurysm/dissection suggests that haploinsufficiency alone by the TGFB3 variant may not result in aneurysm development but that additional factors are required to provoke the aneurysm phenotype.
No takes yet. Share an insight, caveat, or question.
Perik et al. (2023) conducted an observational in Loeys-Dietz syndrome type 5 (TGFB3-related thoracic aortic aneurysm and dissection) (n=27). TGFB3 c.787G>C p.(Asp263His) founder variant vs. Published literature cohort of 82 patients with other TGFB3 variants was evaluated on Penetrance of thoracic aortic aneurysm and dissection (TAAD) (p=0.0288). The Belgian TGFB3 p.(Asp263His) founder variant showed a low 15% penetrance of thoracic aortic aneurysm/dissection (4/27 carriers) compared to 40% in published TGFB3 cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: